NASDAQ: CDIOCardio Diagnostics Holdings Inc Stock
$1.43+0.01 (+0.7%)
Updated Jun 2, 2023
CDIO Price
$1.43
Fair Value Price
N/A
Market Cap
$13.87M
52 Week Low
$0.80
52 Week High
$10.25
P/E
-1.1x
P/B
4.05x
P/S
39,292.53x
PEG
N/A
Dividend Yield
N/A
Revenue
$950.00
Earnings
-$5.40M
Gross Margin
100%
Operating Margin
-40,730.21%
Profit Margin
-568,794.5%
Debt to Equity
1.5
Operating Cash Flow
N/A
Beta
0.13
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CDIO Overview
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
Zen Score
–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CDIO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CDIO is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CDIO is poor value based on its book value relative to its share price (4.05x), compared to the US Diagnostics & Research industry average (4.02x)
P/B vs Industry Valuation
CDIO is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more CDIO due diligence checks available for Premium users.
Be the first to know about important CDIO news, forecast changes, insider trades & much more!
CDIO News
Valuation
CDIO price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-1.1x
Industry
31.67x
Market
52.69x
CDIO price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.05x
Industry
4.02x
CDIO is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CDIO's financial health
Profit margin
Revenue
$0.0
Net Income
-$1.0M
Profit Margin
0%
CDIO's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$8.6M
Liabilities
$5.1M
Debt to equity
1.5
CDIO's short-term assets ($8.14M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CDIO's short-term assets ($8.14M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CDIO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.6M
Investing
-$52.7k
Financing
$4.3M
CDIO vs Diagnostic & Research Stocks
Cardio Diagnostics Holdings Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.